Found: 69
Select item for more details and to access through your institution.
Who should be transplanted in first remission of acute myeloid leukaemia?
- Published in:
- 2011
- By:
- Publication type:
- journal article
The British Connection (Book Review).
- Published in:
- 1986
- By:
- Publication type:
- Book Review
The Challenge of AML in Older Patients.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2013, v. 5, n. 1, p. 1, doi. 10.4084/MJHID.2013.038
- By:
- Publication type:
- Article
Tris(8-hydroxyquinolinato)gallium(III)-Loaded Copolymer Micelles as Cytotoxic Nanoconstructs for Cosolvent-Free Organometallic Drug Delivery.
- Published in:
- Small, 2011, v. 7, n. 12, p. 1635, doi. 10.1002/smll.201100405
- By:
- Publication type:
- Article
Treatment of acute myeloid leukaemia.
- Published in:
- Clinical Medicine, 2013, v. 13, p. s58, doi. 10.7861/clinmedicine.13-6-s58
- By:
- Publication type:
- Article
Homozygous MHC Genotypes and Longevity.
- Published in:
- Human Heredity, 1994, v. 44, n. 5, p. 271, doi. 10.1159/000154229
- By:
- Publication type:
- Article
A call for greater flexibility in the use of public transport.
- Published in:
- British Journal of Community Nursing, 2007, v. 12, n. 7, p. 308, doi. 10.12968/bjcn.2007.12.7.23824
- By:
- Publication type:
- Article
Understanding and tackling fear of crime among older people.
- Published in:
- British Journal of Community Nursing, 2006, v. 11, n. 9, p. 387, doi. 10.12968/bjcn.2006.11.9.21761
- By:
- Publication type:
- Article
Book reviews.
- Published in:
- 2001
- By:
- Publication type:
- Book Review
Influence of the major histocompatibility complex on age at onset of chronic lymphoid leukaemia.
- Published in:
- International Journal of Cancer, 1996, v. 65, n. 2, p. 134, doi. 10.1002/(SICI)1097-0215(19960117)65:2<134::AID-IJC2>3.0.CO;2-#
- By:
- Publication type:
- Article
AML: New Drugs but New Challenges.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Should We GO to FLAG-Ida?.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S56, doi. 10.1016/j.clml.2018.06.056
- By:
- Publication type:
- Article
Treatment of Older Patients With Newly Diagnosed AML Unfit for Traditional Therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
AML: The Next Question.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S131, doi. 10.1016/j.clml.2017.08.061
- By:
- Publication type:
- Article
Side-by-side comparison of published small molecule inhibitors against thapsigargin-induced store-operated Ca<sup>2+</sup> entry in HEK293 cells.
- Published in:
- PLoS ONE, 2024, v. 19, n. 1, p. 1, doi. 10.1371/journal.pone.0296065
- By:
- Publication type:
- Article
GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 701, doi. 10.1111/bjh.12317
- By:
- Publication type:
- Article
Does BCR/ ABL1 positive Acute Myeloid Leukaemia Exist?
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 4, p. 541, doi. 10.1111/bjh.12301
- By:
- Publication type:
- Article
The HSP90 inhibitor NVP- AUY922- AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 1, p. 57, doi. 10.1111/bjh.12215
- By:
- Publication type:
- Article
Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (Hi DAC) based induction chemotherapy.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 6, p. 861, doi. 10.1111/bjh.12178
- By:
- Publication type:
- Article
Prognostic and therapeutic relevance of c- FLIP in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 2, p. 188, doi. 10.1111/bjh.12108
- By:
- Publication type:
- Article
The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 4, p. 519, doi. 10.1111/j.1365-2141.2012.09165.x
- By:
- Publication type:
- Article
Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 1, p. 54, doi. 10.1111/j.1365-2141.2009.07710.x
- By:
- Publication type:
- Article
Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 5, p. 598, doi. 10.1111/j.1365-2141.2009.07663.x
- By:
- Publication type:
- Article
The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 3, p. 318, doi. 10.1111/j.1365-2141.2009.07604.x
- By:
- Publication type:
- Article
Nuclear factor-κB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 5, p. 661, doi. 10.1111/j.1365-2141.2008.07392.x
- By:
- Publication type:
- Article
Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 4, p. 483, doi. 10.1111/j.1365-2141.2008.07053.x
- By:
- Publication type:
- Article
Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 1, p. 96, doi. 10.1111/j.1365-2141.2006.06403.x
- By:
- Publication type:
- Article
The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Del (9q) AML: clinical and cytological characteristics and prognostic implications.
- Published in:
- British Journal of Haematology, 2005, v. 129, n. 2, p. 210, doi. 10.1111/j.1365-2141.2005.05445.x
- By:
- Publication type:
- Article
Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes.
- Published in:
- 2004
- By:
- Publication type:
- Letter
correspondence Long-term survival of myelodysplastic patients with macrocytosis.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Prognosis of myelodysplasic patients: non-parametric multiple regression analysis of populations stratified by mean corpuscular volume and marrow myeloblast number.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 1, p. 87, doi. 10.1046/j.1365-2141.2002.03783.x
- By:
- Publication type:
- Article
Current Controversies: Which Patients With Acute Myeloid Leukaemia Should Receive A Bone Marrow Transplantation? – An Adult Treater's View.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 2, p. 357, doi. 10.1046/j.1365-2141.2002.03698.x
- By:
- Publication type:
- Article
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 2, p. 385, doi. 10.1046/j.1365-2141.2002.03724.x
- By:
- Publication type:
- Article
Comparison of ‘sequential’ versus ‘standard’ chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 3, p. 713, doi. 10.1046/j.1365-2141.2001.02785.x
- By:
- Publication type:
- Article
The Emerging Role of Targeted Therapy for Hematologic Malignancies: Update on Bortezomib and Tipifarnib.
- Published in:
- Oncologist, 2007, v. 12, n. 3, p. 281, doi. 10.1634/theoncologist.12-3-281
- By:
- Publication type:
- Article
Treatment of Acute Leukaemias – New Directions for Clinical Research.
- Published in:
- 2003
- By:
- Publication type:
- Book Review
The MEK inhibitor, PD98059, reduces survival but does not block acute myeloid leukemia blast maturation in vitro.
- Published in:
- European Journal of Haematology, 2000, v. 64, n. 4, p. 211, doi. 10.1034/j.1600-0609.2000.90139.x
- By:
- Publication type:
- Article
A randomised evaluation of low‐dose cytosine arabinoside plus lenalidomide versus single‐agent low‐dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI‐1 trial.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 871, doi. 10.1111/bjh.19220
- By:
- Publication type:
- Article
A randomised evaluation of low‐dose Ara‐C plus pegylated recombinant arginase BCT‐100 versus low dose Ara‐C in older unfit patients with acute myeloid leukaemia: Results from the LI‐1 trial.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 5, p. 573, doi. 10.1111/bjh.18560
- By:
- Publication type:
- Article
A randomised comparison of FLAG‐Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 528, doi. 10.1111/bjh.18195
- By:
- Publication type:
- Article
Therapy for isocitrate dehydrogenase 2 (IDH2)<sup>R172</sup>‐mutant acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 6, p. 1348, doi. 10.1111/bjh.17981
- By:
- Publication type:
- Article
Treatment intensification with FLAG‐Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long‐term follow up of the MRC AML15 trial.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 6, p. 1344, doi. 10.1111/bjh.17974
- By:
- Publication type:
- Article
Gemtuzumab ozogamicin in (KMT2A)‐rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 5, p. e50, doi. 10.1111/bjh.17943
- By:
- Publication type:
- Article
A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 298, doi. 10.1111/bjh.17501
- By:
- Publication type:
- Article
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study*.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 5, p. 832, doi. 10.1111/bjh.17336
- By:
- Publication type:
- Article
Combination of a mitogen‐activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion‐based residual disease and prevents re‐expansion of FLT3‐ITD acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 2, p. 231, doi. 10.1111/bjh.16665
- By:
- Publication type:
- Article
The clinical impact of mutant DNMT3A R882 variant allele frequency in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. e81, doi. 10.1111/bjh.16486
- By:
- Publication type:
- Article
Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. 852, doi. 10.1111/bjh.16239
- By:
- Publication type:
- Article
Twenty five years of UK trials in acute myeloid leukaemia: what have we learned?
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 1, p. 86, doi. 10.1111/bjh.16359
- By:
- Publication type:
- Article